Corbevax vaccine for kids: All you need to know about this indigenous jab

Corbevax is India's first indigenously developed RBD-protein subunit vaccine that has been manufactured by Hyderabad-based Biological E Limited..

Vaccination of children in the 12-14 year age group against the coronavirus (Covid-19) disease began in most parts of the country on Wednesday. Registration for the same is being done on the government's COWIN portal. The Union health ministry had informed states and Union territories about the precautions and guidelines that are to be followed. Children are being inoculated with India's homegrown vaccine - Corbevax.

Corbevax is the third made-in-India vaccine against coronavirus(MINT_PRINT)

Here’s more about the country’s third indigenous anti-Covid vaccine that has been manufactured by Hyderabad-based Biological E Limited.

Govt nod and EUA

In September 2021, Biological E had received the nod to conduct the second and third phases of clinical trials of Corbevax on children and adolescents in the age group of 15-18 years. The Centre had received a nod for the roll-out of the vaccine in December 2021. Corbevax had received the emergency use authorization (EUA) from the Drugs Controller General of India (DCGI) in February 2022 for children in the age group of 12 to 18 years.

How the vaccine works

Corbevax is India's first indigenously developed RBD-protein subunit vaccine. Unlike any other vaccine, it uses a recombinant protein platform that targets spike protein on the virus. The vaccine injects a volume of cloned spike proteins, instead of instructing cells to replicate it. It reduces the virus' ability to cause any serious diseases.

Dosage and safety

Children will be administered with two doses at an interval of 28 days – four weeks after the first dose. The vaccine is stored at 2 to 8 degrees Celsius. Biological E has supplied 5 crore doses of Corbevax to the Centre, which has then distributed the same to states.

The authorities have said the vaccine has gone through rigorous trials of safety and efficacy. “This has been verified and tested. In any case, it has been given a EUA. Without testing the safety, the vaccine would not have been released,” Dr Anil Arora, senior consultant, institute of gastroenterology, Sir Ganga Ram hospital, told Hindustan Times.

He added, “What the mandate is that anybody who is given the vaccine needs to be tracked for adverse side effects. This data has to be submitted by vaccine manufacturers. So, it has been thoroughly tried and tested and safe.” He further said hesitancy should not be a problem and urged children to get vaccinated.

Cost of the vaccine

Corbevax will cost ₹990 per dose in private hospitals and ₹145 for each dose in government facilities.